Our Goal

 

To reduce symptoms in individuals with mitochondrial diseases, such as Friedreich’s Ataxia.

Our Passion

Our passion for solutions is only matched by our sense of urgency.

Chondrial Therapeutics, Inc. is an emerging biotechnology company focused on the treatment of rare mitochondrial diseases.

Find Out More

small girl in wheelchair

We are dedicated to the pursuit of scientific research leading to the treatment for Friedreich’s Ataxia and other mitochondrial diseases.

Mission

To discover and develop orphan drugs that target and treat rare debilitating mitochondrial diseases, such as Friedreich’s Ataxia.

Approach

To utilize our proprietary protein replacement platform to initially target Friedreich’s Ataxia and then other rare mitochondrial diseases.

Goal

To reduce symptoms in individuals with mitochondrial diseases.

Our Partners